In one paragraphArticle in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Carla Johanna Sommer-PlüssMolecular Pharmacy Research Group, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
Céline LeiggenerMolecular Pharmacy Research Group, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
Elira NikciMolecular Pharmacy Research Group, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
Riccardo Vincenzo MancusoMolecular Pharmacy Research Group, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.ORCID 0000-0003-4242-6096 Said RabbaniMolecular Pharmacy Research Group, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.ORCID 0000-0002-2666-8645 Christina LamersMolecular Pharmacy Research Group, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.ORCID 0000-0003-0962-8171 Daniel RicklinMolecular Pharmacy Research Group, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
Funding
Deutsche Forschungsgemeinschaft 514664767Deutsche Forschungsgemeinschaft 553123880Forschungsfond Universität Basel Nachwuchsförderung 4606712Swiss National Science Foundation 205321_204607Swiss National Science Foundation 31003A_176104
6 · The paper itselfAbstract
Indexed as
CD18 AntigensBinding SitesHumansLigandsProtein BindingRecombinant ProteinsSurface Plasmon ResonanceCD18 AntigensLigandsRecombinant ProteinsCD11d/CD18complementCR3CR4drug discoveryLFA-1β2-integrin receptors
Identifiers
PMID40001541
PMCPMC11853025
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390